TERUMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,627 JPY | +0.90% |
|
-1.35% | +13.67% |
| Apr. 12 | Penumbra, Inc. : The underdog in healthcare |  |
| Mar. 18 | Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 906B 5.81B | Sales 2025 * | 972B 6.24B | Capitalization | 3,900B 25.03B |
|---|---|---|---|---|---|
| Net income 2024 * | 108B 694M | Net income 2025 * | 125B 803M | EV / Sales 2024 * | 4.33 x |
| Net Debt 2024 * | 23.33B 150M | Net cash position 2025 * | 55.65B 357M | EV / Sales 2025 * | 3.96 x |
| P/E ratio 2024 * |
36.2
x | P/E ratio 2025 * |
31.3
x | Employees | 30,207 |
| Yield 2024 * |
0.83% | Yield 2025 * |
0.91% | Free-Float | 95.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Terumo Corporation
More recommendations
More press releases
More news
| 1 day | +0.90% | ||
| 1 week | -1.35% | ||
| Current month | -2.47% | ||
| 1 month | +0.48% | ||
| 3 months | -3.40% | ||
| 6 months | +25.33% | ||
| Current year | +13.67% |
1 week
2 563.00
2 695.00
1 month
2 513.002 729.50
Current year
2 267.003 014.50
1 year
1 856.003 014.50
3 years
1 708.003 014.50
5 years
1 440.003 014.50
10 years
490.253 014.50
| Managers | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 66 | 81-03-31 |
Naoki Muto
DFI | Director of Finance/CFO | - | - |
Kazuhisa Senshu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shouji Hatano
CMP | Compliance Officer | 64 | 83-03-31 |
Hidenori Nishi
BRD | Director/Board Member | 73 | 20-06-24 |
Shinjiro Sato
BRD | Director/Board Member | 63 | 04-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 0 M€ | +12.19% | ||
| 1.94% | 0 M€ | +15.47% | ||
| 1.90% | 0 M€ | +14.38% | - | |
| 1.82% | 0 M€ | +15.20% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 2,627 | +0.90% | 3,068,600 |
| 24-05-09 | 2,604 | +0.93% | 1,759,100 |
| 24-05-08 | 2,580 | -3.26% | 3,437,700 |
| 24-05-07 | 2,666 | +0.13% | 2,573,200 |
Delayed Quote Japan Exchange, May 10, 2024 at 02:00 am EDT
More quotes
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-05-13
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
2,627
JPY
Average target price
2,976
JPY
Spread / Average Target
+13.28%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.67% | 25.02B | |
| -4.84% | 182B | |
| +0.56% | 110B | |
| -3.35% | 68.11B | |
| +2.39% | 50.53B | |
| +9.36% | 44.8B | |
| +2.70% | 40.7B | |
| +3.43% | 26.53B | |
| -0.32% | 24.96B | |
| +5.22% | 22.86B |
- Stock Market
- Equities
- 4543 Stock
